Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An extranodal lymphoma that arises from the stomach with the bulk of the mass located in the stomach. The vast majority of cases are diffuse large B-cell lymphomas and B-cell lymphomas of the mucosa-associated lymphoid tissue.
Biomarker and diagnostic research for gastric lymphoma has been reported in the published literature.
2 clinical trials registered. Interventions under study include drug therapy. Pipeline includes 2 PHASE2. Research is primarily sponsored by academic and government institutions.
51 publications have been identified in PubMed for gastric lymphoma. Research spans Case Report / Case Series (42%), Review / Meta-Analysis (27%), and Basic Science / Preclinical (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 20 | 42% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 7:21 PM UTC
Research summaries |
13 |
27% |
Laboratory research | 5 | 10% |
Disease patterns and progression | 5 | 10% |
Testing and diagnosis research | 4 | 8% |
Clinical study results | 1 | 2% |
Banwala S (2026). [PMID: 41620923](https://pubmed.ncbi.nlm.nih.gov/41620923/). *Med Chem*. [Diagnostic / Biomarker]
Tatoğlu MT (2026). [PMID: 41663627](https://pubmed.ncbi.nlm.nih.gov/41663627/). *J Ultrasound*. [Case Report / Case Series]
Zhang T (2026). [PMID: 41229386](https://pubmed.ncbi.nlm.nih.gov/41229386/). *QJM*. [Review / Meta-Analysis]
Salvatori S (2026). [PMID: 41595250](https://pubmed.ncbi.nlm.nih.gov/41595250/). *Cancers (Basel)*. [Review / Meta-Analysis]
Fu MY (2026). [PMID: 41809217](https://pubmed.ncbi.nlm.nih.gov/41809217/). *World journal of gastrointestinal pharmacology and therapeutics*. [Basic Science / Preclinical]
Wei J (2026). [PMID: 41978406](https://pubmed.ncbi.nlm.nih.gov/41978406/). *Beijing Da Xue Xue Bao Yi Xue Ban*. [Diagnostic / Biomarker]
Yeh NS (2026). [PMID: 41971029](https://pubmed.ncbi.nlm.nih.gov/41971029/). *Front Vet Sci*. [Case Report / Case Series]
Mülder DT (2026). [PMID: 41236450](https://pubmed.ncbi.nlm.nih.gov/41236450/). *Gastroenterology*. [Review / Meta-Analysis]
Aggarwal K (2026). [PMID: 38445894](https://pubmed.ncbi.nlm.nih.gov/38445894/). *Cardiol Rev*. [Review / Meta-Analysis]
Li C (2026). [PMID: 42169886](https://pubmed.ncbi.nlm.nih.gov/42169886/). *J Gastrointest Oncol*. [Case Report / Case Series]
AI-curated news mentioning gastric lymphoma
Updated Apr 14, 2026
A recent study explores the endoscopic characteristics of primary gastric lymphoma, providing insights that may help predict treatment response. This research could enhance diagnostic accuracy and therapeutic strategies for affected patients.
A recent study highlights the diagnostic challenges posed by benign thyroid nodules that can mimic residual disease in patients with concurrent thyroid and gastric diffuse large B-cell lymphoma. The research emphasizes the importance of ultrasound-guided biopsy for accurate diagnosis.